TriMark Publications, LLC’s “Nuclear Cardiology Markets” is now available at ReportsnReports.com.

Dallas, TX -- (SBWire) -- 08/09/2011 --Nuclear imaging for cardiac diseases helps in accurately diagnosing the disease and blood flow blockages. Gamma cameras and positron emission tomography (PET) scanners are the key imaging devices used for cardiac procedures. Though nuclear imaging in cardiology faces competition from other methods, the impact is relatively limited. Demand for diagnostic medical imaging equipment is mainly driven by the number of diagnostic procedures. The application of PET's clinical use, its combined use with other imaging equipment and the current shift to PET/CT imaging and SPECT/CT imaging are the important factors driving the dramatic rise in procedural volumes.

This TriMark Publications study discusses key products in nuclear cardiology and examines the trends that are stimulating this market. This market research report includes a survey of all major companies actively engaged in marketing, manufacturing or developing nuclear cardiological instrumentation, with each company discussed in depth. The primarily focus on three major segments of the nuclear cardiology market: 1) devices, 2) PACS (picture archiving and communications systems) and RIS (radiology information systems) and 3) radiopharmaceuticals. This examination discusses products, trends, new developments and compensation issues that are currently affecting or are likely to affect the nuclear cardiology market soon. Detailed tables and charts with sales forecasts and market share data are also included.

Table Of Contents

1. Overview
1.2 Scope
1.3 Methodology
1.4 Executive Summary

2. Overview of Cardiovascular Diseases (CVD)
2.1 Heart Diseases in Men
2.2 Heart Diseases in Women
2.3 Prevalence of Cardiovascular Diseases in the U.S.
2.3.1 Prevalence of CVD in Ethnic Groups: U.S.
2.3.2 Global CVD Mortality
2.3.3 Economic Cost of CVD in the U.S.
2.3.4 CVD Mortality in Europe
2.4 CVD Mortality in China
2.5 CVD Prevalence and Mortality in India
2.6 Aneurysm
2.6.1 Detection of Aneurysm
2.7 Angina
2.7.1 Prevalence of Angina
2.8 Atherosclerosis
2.8.1 Imaging of Atherosclerosis
2.9 Cerebrovascular Accident (Stroke)
2.9.1 Embolic Stroke
2.9.2 Cerebral Hemorrhage
2.9.3 Subarachnoid Hemorrhage
2.9.4 Imaging Devices Used for Detecting Stroke
2.10 Congestive Heart Failure
2.10.1 Imaging Modalities Used for the Detection of Congestive Heart Failure
2.11 Coronary Artery Disease (CAD)
2.11.1 Imaging of CAD
2.12 Nuclear Imaging for Heart Diseases
2.12.1 Technological Advances in Nuclear Cardiology
2.12.1.1 Development of New Pharmacologic Stress Agents and Protocols
2.12.1.2 Development of New Tracers
2.12.1.3 New Computer Algorithms and Tools
2.12.1.3 New Gamma Camera Technology
2.12.1.4 Hybrid Systems and Image Fusion
2.13 Trends in Cardiac Imaging

3. Popular Modalities Used in Nuclear Cardiology
3.1 SPECT/CT
3.1.1 General Architecture of SPECT/CT
3.1.2 Myocardial Perfusion Imaging: CT Based Attenuation Correction
3.1.4 SPECT/CT for Cardiac Disease Detection: An Economic Conundrum
3.1.4.1 SPECT/CT from the Physician’s Point of View
3.1.4.2 Cost Effectiveness vs. Cost and Reimbursement
3.1.4.3 Factors to Drive Sales and Utilization of SPECT/CT
3.1.4.4 Newer SPECT Cameras
3.1.4.5 New Ultrafast Camera Designs
3.1.4.6 Basic Design of a Gamma Camera
3.2 Positron Emission Tomography (PET)
3.2.1 Basic Design of a PET System
3.2.2 Application of PET in Cardiology
3.2.3 PET and Heart Disease Diagnosis
3.2.4 PET and Heart Disease Staging
3.2.5 Reimbursement Cuts for Cardiac PET in 2011
3.2.6 Growth of PET in Cardiology
3.2.6.1 PET/CT Hybridization
3.2.6.2 Cost Considerations in PET Scanners
3.2.7 PET/CT in Cardiology
3.2.7.1 Positron Emitting Tracers
3.3.1 The Resting Electrocardiogram (ECG)
3.3.2 The Exercise Stress Test (Treadmill Stress Test, TMT)
3.3.3 Echocardiography
3.3.4 Magnetic Resonance Imaging (MRI)
3.3.5 Multi-slice Computed Tomography (MSCT)
3.3.6 Contrast Coronary Angiography (CA) and Intravascular Ultrasound (IVUS)

4. Nuclear Medicine
4.1 Diagnostic Radiopharmaceuticals
4.2 Suppliers of Radioisotopes
4.3 Isotopes Used in Medicine
4.4 Cyclotron Radioisotopes
4.5 Radiopharmaceuticals in PET Imaging
4.6 Radiopharmaceuticals for Clinical Cardiac PET Imaging
4.6.1 Nitrogen-13 Ammonia
4.6.2 Rubidium-82
4.6.3 Oxygen-15 Water
4.6.4 Fluorine-18 Fluorodeoxyglucose
4.7 Generator Produced PET Radiopharmaceuticals
4.8 Radiopharmaceuticals in SPECT

5. Picture Archiving and Communication Systems (PACS) in Cardiology
5.1 Trends in Cardiology PACS
5.1.1 Remote Reading of PACS
5.1.2 Double-Digit Growth in CardioPACS

6. Advances in Nuclear Cardiology
6.1 Myocardial Function
6.2 Myocardial Perfusion
6.3 Gated Myocardial Perfusion SPECT
6.4 Advances in Software for Gated SPECT
6.5 Gated Myocardial Perfusion SPECT in the Era of Multi-Detector CT
6.6 PET and Imaging of Myocardial Metabolism
6.7 Imaging Myocardial Innervation
6.8 Radionuclide Imaging of Atherosclerotic Lesions
6.9 Stem Cell Imaging
6.10 Gene Therapy

http://www.reportsnreports.com/reports/75219-nuclear-cardiology-markets.html

Browse All: http://www.reportsnreports.com/market-research/pharmaceuticals/

About ReportsnReports
ReportsnReports is an online library of over 100,000+ market research reports and in-depth market research studies & analysis of over 5000 micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.

Follow us on Twitter: http://twitter.com/marketsreports
Our Facebook Page: http://www.facebook.com/pages/ReportsnReports/191441427571689
Blog: http://www.reportsnreportsblog.com/